+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin



Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin



Therapeutic Drug Monitoring 18(1): 34-39



High concentrations of digoxin-like immunoreactive substances (DLIS) artificially increase serum digoxin concentrations. However, DLIS are absent in the protein-free ultrafiltrate because of their strong binding with serum macromolecules, whereas approximately 75% of digoxin can be found in the ultrafiltrate. Using regression analysis, we devised equations by which total digoxin concentration can be calculated from free digoxin and albumin concentrations in serum. We used two different assays, fluorescence polarization and chemiluminescence, for measuring total and free-digoxin concentrations in sera. Both equations were very similar. Because measured concentrations of digoxin in the serum exhibit DLIS interferences, the measured concentrations were sometimes higher in volume-expanded patients than the calculated digoxin concentrations. We also estimated the extent of interferences from DLIS by subtracting the calculated digoxin concentration from the measured digoxin concentration in volume-expanded patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008624573

Download citation: RISBibTeXText

PMID: 8848818


Related references

Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations. American Journal of Clinical Pathology 111(3): 406-410, 1999

Monitoring free digoxin instead of total digoxin in patients with congestive heart failure and high concentrations of digoxin-like immunoreactive substances. Clinical Chemistry 36(12): 2121-2123, 1990

Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency. Yao Xue Xue Bao 32(3): 174-177, 1997

Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay. Clinical Chemistry 35(2): 323-324, 1989

Postmortem digoxin-like immunoreactive substances (DLIS) in patients not treated with digoxin. Human & Experimental Toxicology 18(2): 67-70, 1999

Postmortem digoxin-like immunoreactive substances (Dlis) in patients not treated with digoxin. Human & Experimental Toxicology 18(2): 67-70, 1999

Measurement of digoxin like immunoreactive substances dlis from patients receiving digoxin. Clinical Chemistry 33(6): 890, 1987

Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function. Clinical Pharmacy 5(10): 810-816, 1986

Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients. Therapeutic Drug Monitoring 13(6): 523-527, 1991

Monitoring free digoxin levels for patients with congestive heart failure eliminates interferences from digoxin like immunoreactive substances. Clinical Chemistry 36(6): 1030, 1990

Determination of free serum digoxin concentrations in digoxin toxic patients after administration of digoxin fab antibodies. Therapeutic Drug Monitoring 14(2): 147-154, 1992

Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay. Clinical Chemistry 33(8): 1490-1491, 1987

The pharmacokinetics of digoxin immune fab total digoxin and free digoxin in patients with renal impairment. Pharmacotherapy 9(3): 175, 1989

Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations. American Journal of Clinical Pathology 115(4): 600-604, 2001

Effect of endogenous digoxin-like immunoreactive factors on serum digoxin measurement by a new turbidimetric digoxin immunoassay. Clinical Chemistry 49(S6): A78, 2003